Contact

All Stories

  1. Evolution of CRISPR-enabled biosensors for amplification-free nucleic acid detection

    Article • Trends in Biotechnology, January 2024, Elsevier

    Joao Conde

  2. Bioinspired and biomimetic cancer-cell-derived membrane nanovesicles for preclinical tumor-targeted nanotheranostics

    Article • Cell Reports Physical Science, November 2023, Elsevier

    Joao Conde

  3. Intratumoural Delivery of mRNA Loaded on a Cationic Hyper-Branched Cyclodextrin-Based Polymer Induced an Anti-Tumour Immunological Response in Melanoma

    Article • Cancers, July 2023, MDPI AG

    Joao Conde

  4. Engineered Liposomes in Interventional Theranostics of Solid Tumors

    Article • ACS Biomaterials Science & Engineering, July 2023, American Chemical Society (ACS)

    Joao Conde

  5. A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas

    Article • Materials Today Bio, June 2023, Elsevier

    Joao Conde

  6. Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine

    Article • Military Medical Research, April 2023, Springer Science + Business Media

    Joao Conde

  7. Hydrogels for RNA delivery

    Article • Nature Materials, March 2023, Springer Science + Business Media

    Joao Conde

  8. mRNA therapy at the convergence of genetics and nanomedicine

    Article • Nature Nanotechnology, March 2023, Springer Science + Business Media

    Joao Conde

  9. Biopolymeric Coatings for Local Release of Therapeutics from Biomedical Implants

    Article • Advanced Science, February 2023, Wiley

    Joao Conde

  10. Technological challenges of biomembrane-coated top-down cancer nanotherapy

    Article • Nature Reviews Bioengineering, January 2023, Springer Science + Business Media

    Joao Conde

  11. ‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective

    Article • Chemical Society Reviews, January 2023, Royal Society of Chemistry

    Joao Conde

  12. Using gold nanobeacons as a theranostic technique to recognize, detect, and inhibit specific nucleic acids

    Article • STAR Protocols, December 2022, Elsevier

    Joao Conde

  13. Nucleic acid-based therapy for brain cancer: Challenges and strategies

    Article • Journal of Controlled Release, October 2022, Elsevier

    Joao Conde

  14. Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer

    Article • Biomaterials Advances, September 2022, Elsevier

    Joao Conde

  15. Gold Nanoconjugates for miRNA Modulation in Cancer Therapy: From miRNA Silencing to miRNA Mimics

    Article • ACS Materials Au, August 2022, American Chemical Society (ACS)

    Joao Conde

  16. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

    Article • The Lancet, August 2022, Elsevier

    Dr Amin Mousavi Khaneghah, Professor Andrew Toyin Olagunju, Dr Mohammad Hosein Amirzade-Iranaq, Dr Aidin Abedi, Dr Md Nuruzzaman Khan, Additional Prof (Dr.) Paramdeep Singh, Dr Ali Fatehizadeh, Dr. Ahmed I. Hasaballah, Professor Vijay Kumar Chattu, Assistant Professor Ashok Pandey, Laszlo Lorenzovici, Turki Alanzi, Sumaira Mubarik, Dr Javad Sharifi Rad, Prof Maha El Tantawi, Sok King Ong, Dr Ashish D Badiye, Joao Conde, Prof. Mohsen Safaei, Dr Akshaya Srikanth Bhagavathula, Dr Mohammad Hassan Emamian, Gizachew Taddesse AKALU, Dr Fakher Rahim, Pritik A Shah

  17. Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications

    Article • Small Methods, June 2022, Wiley

    Prof Michael R Hamblin, Joao Conde

  18. Nanodelivery of nucleic acids

    Article • Nature Reviews Methods Primers, April 2022, Springer Science + Business Media

    Joao Conde

  19. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Article • The Lancet Gastroenterology & Hepatology, April 2022, Elsevier

    Prof. Maciej Banach, Professor Yousef Khader, Professor Andrew Toyin Olagunju, Dr Ashish D Badiye, Dr Ali Fatehizadeh, Dr. Ahmed I. Hasaballah, Turki Alanzi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Sumaira Mubarik, Dr Javad Sharifi Rad, Sok King Ong, Joao Conde, Dr Akshaya Srikanth Bhagavathula, Prof.Dr. Adnan Kisa

  20. Bioinspired soft nanovesicles for site‐selective cancer imaging and targeted therapies

    Article • Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, March 2022, Wiley

    Joao Conde

  21. Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019

    Article • The Lancet Child & Adolescent Health, March 2022, Elsevier

    Joao Conde, Professor Alina Rodriguez, Sandra Barteit, Professor Stefan Lorkowski, Alexander Mathioudakis

  22. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019

    Article • JAMA Oncology, December 2021, American Medical Association (AMA)

    Dr Sonu Bhaskar, Mr. Amadou Barrow, Dr Senthilkumar Balakrishnan, Joao Conde, Professor Yousef Khader, Professor Andrew Toyin Olagunju, Dr Shariful Islam, Dr Aidin Abedi, ED Doris V. Ortega-Altamirano, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Dr Ashish D Badiye, Dr. Ahmed I. Hasaballah, Professor Vijay Kumar Chattu, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Sumaira Mubarik, Prof Maha El Tantawi, Sok King Ong, Dr Akshaya Srikanth Bhagavathula, Dr. Mohammad Rifat Haider, Prof.Dr. Adnan Kisa, Dr Andre Luiz Sena Guimaraes, Mohamed Mesregah

  23. Prodrug Polymeric Nanoconjugates Encapsulating Gold Nanoparticles for Enhanced X‐Ray Radiation Therapy in Breast Cancer

    Article • Advanced Healthcare Materials, December 2021, Wiley

    Joao Conde

  24. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019

    Article • The Lancet Oncology, December 2021, Elsevier

    Dr Sonu Bhaskar, Dr. Sameh Attia, Mr. Amadou Barrow, Joao Conde, Dr. Alok Atreya, Turki Alanzi, Dr Amin Mousavi Khaneghah, Professor Yousef Khader, Professor Andrew Toyin Olagunju, Dr Shariful Islam, Dr Aidin Abedi, ED Doris V. Ortega-Altamirano, Dr. Jitendra Kumar Singh, Dr Md Nuruzzaman Khan, Dr Fakher Rahim, Mr. Alex Yeshaneh, Professor Ashraf Fawzy Nabhan, Dr. Ahmed I. Hasaballah, Professor Vijay Kumar Chattu, Sumaira Mubarik, Prof Maha El Tantawi, Sok King Ong, Dr Akshaya Srikanth Bhagavathula, Prof.Dr. Adnan Kisa, Mohamed Mesregah

  25. Machine learning for next-generation nanotechnology in healthcare

    Article • Matter, October 2021, Elsevier

    Joao Conde

  26. Nanomedicine-based strategies to target and modulate the tumor microenvironment

    Article • Trends in Cancer, September 2021, Elsevier

    Joao Conde

  27. Child Mortality Trends and Targets: GBD 2019 Findings

    Article • The Lancet, August 2021, Elsevier

    Dr Shrikant Pawar, Turki Alanzi, Dr Yuan-Pang Wang, Dr Amr Hassan, Dr Sheikh M Alif, Joao Conde, Dr. Alok Atreya, Mr Ferry Efendi, Getinet Ayano, Dr Amin Mousavi Khaneghah, Professor HESHAM M. AL-MEKHLAFI, Dr Shariful Islam, Dr Aidin Abedi, Dr Md Nuruzzaman Khan, Dr Ashish D Badiye, Dr Nelsensius Klau Fauk, Dr. Bolajoko O. Olusanya, Professor Erkin Mirrakhimov, Prof Tommi Vasankari, Dr. Ahmed I. Hasaballah, Professor Vijay Kumar Chattu, Assistant Professor Ashok Pandey, Mr Nauman Khalid, Prof Maha El Tantawi, Dr Akshaya Srikanth Bhagavathula, Dr. Mohammad Rifat Haider, Prof.Dr. Adnan Kisa, Professor Yousef Khader, Kathryn H. Jacobsen

  28. Facts and Figures on Materials Science and Nanotechnology Progress and Investment

    Article • ACS Nano, July 2021, American Chemical Society (ACS)

    Joao Conde

  29. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression

    Article • ACS Central Science, April 2021, American Chemical Society (ACS)

    Joao Conde

  30. CRISPR Systems for COVID-19 Diagnosis

    Article • ACS Sensors, January 2021, American Chemical Society (ACS)

    Joao Conde

  31. Ultrahigh Penetration and Retention of Graphene Quantum Dot Mesoporous Silica Nanohybrids for Image Guided Tumor Regression

    Article • ACS Applied Bio Materials, January 2021, American Chemical Society (ACS)

    Joao Conde

  32. Controlled delivery of gold nanoparticle-coupled miRNA therapeuticsviaan injectable self-healing hydrogel

    Article • Nanoscale, January 2021, Royal Society of Chemistry

    Joao Conde

  33. Revisiting gene delivery to the brain: silencing and editing

    Article • Biomaterials Science, January 2021, Royal Society of Chemistry

    Joao Conde

  34. “Swallowing the doctor”: an interview with João Conde about the future of nanomedicine

    Article • Communications Biology, October 2020, Springer Science + Business Media

    Joao Conde

  35. Biomimetic cancer cell membrane-coated nanosystems as next-generation cancer therapies

    Article • Expert Opinion on Drug Delivery, September 2020, Taylor & Francis

    Joao Conde

  36. Why Go NANO on COVID-19 Pandemic?

    Article • Matter, September 2020, Elsevier

    Joao Conde

  37. Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic

    Article • Trends in Cancer, September 2020, Elsevier

    Joao Conde

  38. Tetrazine Carbon Nanotubes for Pretargeted In Vivo “Click‐to‐Release” Bioorthogonal Tumour Imaging

    Article • Angewandte Chemie, August 2020, Wiley

    Joao Conde

  39. Nanotechnology-based disinfectants and sensors for SARS-CoV-2

    Article • Nature Nanotechnology, July 2020, Springer Science + Business Media

    Joao Conde

  40. Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near‐infrared light mediated cancer therapy

    Article • Communications Biology, June 2020, Springer Science + Business Media

    Joao Conde

  41. Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and N-Propargyl Handles for Drug-Activation

    Article • Journal of the American Chemical Society, May 2020, American Chemical Society (ACS)

    Joao Conde

  42. Composite Hydrogels: Prolonged Local In Vivo Delivery of Stimuli‐Responsive Nanogels That Rapidly Release Doxorubicin in Triple‐Negative Breast Cancer Cells (Adv. Healthcare Mater. 4/2020)

    Article • Advanced Healthcare Materials, February 2020, Wiley

    Joao Conde

  43. Prolonged Local In Vivo Delivery of Stimuli‐Responsive Nanogels That Rapidly Release Doxorubicin in Triple‐Negative Breast Cancer Cells

    Article • Advanced Healthcare Materials, January 2020, Wiley

    Joao Conde

  44. Oral pH sensitive GNS@ab nanoprobes for targeted therapy of Helicobacter pylori without disturbance gut microbiome

    Article • Nanomedicine Nanotechnology Biology and Medicine, August 2019, Elsevier

    Joao Conde

  45. Gastric Parietal Cell and Intestinal Goblet Cell Secretion: a Novel Cell-Mediated In Vivo Metal Nanoparticle Metabolic Pathway Enhanced with Diarrhea Via Chinese Herbs

    Article • Nanoscale Research Letters, March 2019, Springer Science + Business Media

    Joao Conde

  46. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression

    Article • SSRN Electronic Journal, January 2019, Elsevier

    Joao Conde

  47. Cisplatin-Triggered Bioorthogonal Decaging of Amide Bonds for Targeted-Drug Activation in vivo

    Article • November 2018, American Chemical Society (ACS)

    Joao Conde

  48. Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook

    Article • Advanced Materials, May 2018, Wiley

    Joao Conde

  49. Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma

    Article • ACS Nano, April 2018, American Chemical Society (ACS)

    Joao Conde

  50. Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells

    Article • PLOS One, February 2018, PLOS

    Dr Pedro Viana Baptista, Joao Conde

  51. Displaying biofunctionality on materials through templated self-assembly

    Article • January 2018, Elsevier

    Joao Conde

  52. Handbook of Nanomaterials for Cancer Theranostics

    Article • January 2018, Elsevier

    Joao Conde

  53. Fullerene: biomedical engineers get to revisit an old friend

    Article • Materials Today, October 2017, Elsevier

    Masoud Mozafari, Joao Conde

  54. Smart NIR linear and nonlinear optical nanomaterials for cancer theranostics: Prospects in photomedicine

    Article • Progress in Materials Science, July 2017, Elsevier

    Joao Conde

  55. Plasmonic gold nanoparticles for detection of fungi and human cutaneous fungal infections

    Article • Analytical and Bioanalytical Chemistry, June 2017, Springer Science + Business Media

    Professor Hugh James Byrne, Joao Conde

  56. Designing Hydrogels for On-Demand Therapy

    Article • Accounts of Chemical Research, March 2017, American Chemical Society (ACS)

    Joao Conde

  57. 3D hydrogel scaffold doped with 2D graphene materials for biosensors and bioelectronics

    Article • Biosensors and Bioelectronics, March 2017, Elsevier

    Joao Conde

  58. Empowering the Potential of Cell-Penetrating Peptides for Targeted Intracellular Delivery via Molecular Self-Assembly

    Article • January 2017, Springer Science + Business Media

    Joao Conde

  59. Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging

    Article • Biomaterials, November 2016, Elsevier

    Joao Conde

  60. Local microRNA delivery targets Palladin and prevents metastatic breast cancer

    Article • Nature Communications, September 2016, Springer Science + Business Media

    Joao Conde

  61. Chiral Antioxidant-based Gold Nanoclusters Reprogram DNA Epigenetic Patterns

    Article • Scientific Reports, September 2016, Springer Science + Business Media

    Joao Conde

  62. Revisiting the ‘One Material Fits All’ Rule for Cancer Nanotherapy

    Article • Trends in Biotechnology, August 2016, Elsevier

    Joao Conde

  63. Revisiting the classification of NIR-absorbing/emitting nanomaterials for in vivo bioapplications

    Article • NPG Asia Materials, August 2016, Springer Science + Business Media

    Joao Conde

  64. Biomaterials for Abrogating Metastasis: Bridging the Gap between Basic and Translational Research

    Article • Advanced Healthcare Materials, July 2016, Wiley

    Joao Conde

  65. Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model

    Article • Nature Materials, July 2016, Springer Science + Business Media

    Joao Conde

  66. Gold nanoprisms as a hybrid in vivo cancer theranostic platform for in situ photoacoustic imaging, angiography, and localized hyperthermia

    Article • Nano Research, February 2016, Tsinghua University Press

    Joao Conde

  67. Dual-Color Emissive Upconversion Nanocapsules for Differential Cancer Bioimaging In Vivo

    Article • ACS Nano, January 2016, American Chemical Society (ACS)

    Joao Conde

  68. Editorial: Cancer Nanotheranostics: What Have We Learned So Far?

    Article • Frontiers in Chemistry, January 2016, Frontiers

    Joao Conde

  69. Dual-sensitive hydrogel composite for local release and selective uptake of chemotherapy for the treatment of breast cancer

    Article • Frontiers in Bioengineering and Biotechnology, January 2016, Frontiers

    Joao Conde

  70. RNAi nanomaterials targeting immune cells as an anti-tumor therapy: the missing link in cancer treatment?

    Article • Materials Today, January 2016, Elsevier

    Joao Conde

  71. Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment

    Article • Nature Materials, December 2015, Springer Science + Business Media

    Joao Conde

  72. The Golden Age in Cancer Nanobiotechnology: Quo Vadis?

    Article • Frontiers in Bioengineering and Biotechnology, September 2015, Frontiers

    Joao Conde

  73. Investigating the role of shape on the biological impact of gold nanoparticles in vitro

    Article • Nanomedicine, September 2015, Future Medicine

    Professor Hugh James Byrne, Joao Conde

  74. Significance of the balance between intracellular glutathione and polyethylene glycol for successful release of small interfering RNA from gold nanoparticles

    Article • Nano Research, August 2015, Tsinghua University Press

    Dr Pedro Viana Baptista, Joao Conde

  75. Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects

    Article • Nanomedicine, August 2015, Future Medicine

    Dr Pedro Viana Baptista, Joao Conde

  76. 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics

    Article • Nano Today, August 2015, Elsevier

    Dr Pedro Viana Baptista, Joao Conde

  77. Personalized Medicine: Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment (Adv. Healthcare Mater. 11/2015)

    Article • Advanced Healthcare Materials, August 2015, Wiley

    Joao Conde

  78. Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis

    Article • Scientific Reports, July 2015, Springer Science + Business Media

    Joao Conde

  79. Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells

    Article • Advanced Functional Materials, June 2015, Wiley

    Professor Hugh James Byrne, Joao Conde

  80. POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50Lowering Capacity

    Article • Macromolecular Bioscience, May 2015, Wiley

    Dr Pedro Viana Baptista, Dr Vasco Bonifácio, Professor Alexandra R Fernandes, Joao Conde

  81. Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment

    Article • Advanced Healthcare Materials, May 2015, Wiley

    Joao Conde

  82. The next generation of smart gold nanobeacons: nanotheranostics is ready for prime time

    Article • Nanomedicine, May 2015, Future Medicine

    Joao Conde

  83. Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance

    Article • Proceedings of the National Academy of Sciences, March 2015, Proceedings of the National Academy of Sciences

    Joao Conde

  84. Are RNAi and miRNA therapeutics truly dead?

    Article • Trends in Biotechnology, March 2015, Elsevier

    Joao Conde

  85. RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing

    Article • Nanoscale, January 2015, Royal Society of Chemistry

    Dr Tobias Stöger, Dr Pedro Viana Baptista, Joao Conde

  86. Target-responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: The jack-of-all-trades in cancer nanotheranostics?

    Article • Advanced Drug Delivery Reviews, January 2015, Elsevier

    Joao Conde

  87. A promising road with challenges: where are gold nanoparticles in translational research?

    Article • Nanomedicine, October 2014, Future Medicine

    Dr Pedro Viana Baptista, Joao Conde

  88. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine

    Article • Frontiers in Chemistry, July 2014, Frontiers

    Dr Pedro Viana Baptista, Joao Conde

  89. Antibody–drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics

    Article • Journal of Controlled Release, June 2014, Elsevier

    Dr Pedro Viana Baptista, Joao Conde

  90. Polyurea dendrimer for efficient cytosolic siRNA delivery

    Article • RSC Advances, January 2014, Royal Society of Chemistry

    Dr Vasco Bonifácio, Joao Conde

  91. Multifunctional Gold Nanocarriers for Cancer Theranostics: From Bench to Bedside and Back Again?

    Article • January 2014, Springer Science + Business Media

    Joao Conde

  92. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models

    Article • Biomaterials, October 2013, Elsevier

    Dr Pedro Viana Baptista, Joao Conde

  93. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis

    Article • Nanotoxicology, May 2013, Taylor & Francis

    Dr Pedro Viana Baptista, Professor Alexandra R Fernandes, Joao Conde

  94. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events

    Article • Biomaterials, March 2013, Elsevier

    Dr Pedro Viana Baptista, Joao Conde

  95. Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?

    Article • Frontiers in Pharmacology, January 2013, Frontiers

    Dr Pedro Viana Baptista, Joao Conde

  96. Modification of plasmid DNA topology by ‘histone-mimetic’ gold nanoparticles

    Article • Nanomedicine, November 2012, Future Medicine

    Dr Pedro Viana Baptista, Joao Conde

  97. Design of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing

    Article • ACS Nano, September 2012, American Chemical Society (ACS)

    Dr Pedro Viana Baptista, Joao Conde

  98. Genotoxic effects of occupational exposure to lead and influence of polymorphisms in genes involved in lead toxicokinetics and in DNA repair

    Article • Environment International, August 2012, Elsevier

    Joao Conde

  99. Gold-nanobeacons for real-time monitoring of RNA synthesis

    Article • Biosensors and Bioelectronics, June 2012, Elsevier

    Dr Pedro Viana Baptista, Dr João C Lima, Joao Conde

  100. Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles

    Article • Journal of Nanoparticle Research, June 2012, Springer Science + Business Media

    Dr Pedro Viana Baptista, Joao Conde

  101. Noble Metal Nanoparticles for Biosensing Applications

    Article • Sensors, February 2012, MDPI AG

    Dr Pedro Viana Baptista, Joao Conde

  102. Nanophotonics for Molecular Diagnostics and Therapy Applications

    Article • International Journal of Photoenergy, January 2012, Hindawi Publishing Corporation

    Dr Pedro Viana Baptista, Dr João C Lima, Joao Conde

  103. Alloy metal nanoparticles for multicolor cancer diagnostics

    Article • February 2011, SPIE

    Dr Pedro Viana Baptista, Joao Conde

  104. In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles

    Article • Nanotechnology, November 2010, Institute of Physics Publishing

    Dr Pedro Viana Baptista, Joao Conde

  105. Use of cyclodextrins as scavengers of inhibitory photo-products in light controlled in vitro synthesis of RNA

    Article • Journal of Photochemistry and Photobiology A Chemistry, June 2010, Elsevier

    Dr Pedro Viana Baptista, Dr João C Lima, Joao Conde

  106. RNA quantification using gold nanoprobes - application to cancer diagnostics

    Article • Journal of Nanobiotechnology, January 2010, Springer Science + Business Media

    Dr Pedro Viana Baptista, Joao Conde

  107. Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study

    Article • BMC Cancer, September 2009, Springer Science + Business Media

    Joao Conde